Associate Professor; Medical Director, Structural Heart Disease
University of Nebraska Medical Center
Omaha, Nebraska, United States
Andrew M. Goldsweig, MD, MS, FACC, FSCAI, FSVM, RPVI is an Associate Professor and Medical Director of the Structural Heart Disease Program at the University of Nebraska Medical Center. His research interests include outcomes of SHD procedures. He is a site investigator for the TAVR UNLOAD, Optimize PRO, CHAMPION-AF, ASAP TOO, TRANSCEND, MINT, and PARADIGM AVP3 trials. Andy serves as Governor of the Nebraska ACC Chapter and is a member of the NCDR LAAO Registry Steering Committee and HeartPAC Executive Board. He is Chair of the SCAI SHD Council, a member of the SCAI Publications and and Government Relations Committees, and associate editor for JSCAI. He also serves as an AMA CPT Panel Advisor.
Sunday, February 26, 2023
4:45 PM – 4:55 PM ET
Disclosure information not submitted.
Sunday, February 26, 2023
5:00 PM – 5:10 PM ET
Disclosure information not submitted.
Sunday, February 26, 2023
5:15 PM – 5:25 PM ET
Disclosure information not submitted.
Sunday, February 26, 2023
5:30 PM – 5:40 PM ET
Disclosure information not submitted.
Monday, February 27, 2023
10:00 AM – 10:40 AM ET
Disclosure(s): Inari Medical: Consulting Fees (e.g., advisory boards) (Ongoing)
Monday, February 27, 2023
9:52 AM – 10:00 AM ET
Disclosure(s): Inari Medical: Consulting Fees (e.g., advisory boards) (Ongoing)
Monday, February 27, 2023
10:00 AM – 10:30 AM ET
Disclosure(s): Inari Medical: Consulting Fees (e.g., advisory boards) (Ongoing)
Tuesday, February 28, 2023
10:30 AM – 11:18 AM ET
Disclosure(s): Inari Medical: Consulting Fees (e.g., advisory boards) (Ongoing)